The effect of the endothelin ET A receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction

By Jones R.D.   Wanstall J.C.   Gambino A.   Morice A.H.  

European Journal of Pharmacology, Vol. 374, Iss. 3, 1999-06 ,pp. : 367-375

Elsevier

Access to resources Recommend Favorite

The ET_A Antagonist CI-1020 Inhibits Hypoxic Pulmonary Vasoconstriction in Small Isolated Rat Pulmonary Arteries

By Jones R.D.   Morice A.H.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 2, 1998-04 ,pp. : 177-181

Academic Press

Access to resources Recommend Favorite

Effects of the endothelin ET A receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats

By Itoh H.   Yokochi A.   Yamauchi-Kohno R.   Maruyama K.  

European Journal of Pharmacology, Vol. 376, Iss. 3, 1999-07 ,pp. : 233-238

Elsevier

Access to resources Recommend Favorite

Effect of ET_AReceptor Antagonist on Pulmonary Hypertension and Vascular Reactivity in Rats With Congestive Heart Failure

By Lucas M.   Jasmin J.F.   Dupuis J.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 4, 2001-08 ,pp. : 307-314

Academic Press

Access to resources Recommend Favorite

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

By Horn Evelyn M   Widlitz Allison C   Barst Robyn J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1483-1492

Informa Healthcare

Access to resources Recommend Favorite